Abivax SA American Depositary Shares (ABVX) — Working Capital to Net Assets Ratio
Abivax SA American Depositary Shares (ABVX) has a Working Capital to Net Assets ratio of 105.0% as of March 2026. Working capital of $450.99 Million (current assets of $513.22 Million minus current liabilities of $62.23 Million) is measured against net assets of $429.59 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see ABVX asset base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Abivax SA American Depositary Shares Working Capital to Net Assets (2013–2025)
This chart shows how Abivax SA American Depositary Shares's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 105.0%, reflecting working capital of $450.99 Million against net assets of $429.59 Million USD. Explore Abivax SA American Depositary Shares (ABVX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Working Capital to Net Assets for Abivax SA American Depositary Shares (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Abivax SA American Depositary Shares from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Explore Abivax SA American Depositary Shares (ABVX) long-term investment share to see how much of total assets are deployed in long-term investments.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 107.3% | $488.02 Million | $455.01 Million | $551.01 Million | $62.99 Million | ▼ -84.5 pp |
| 2024 | 191.8% | $77.84 Million | $40.58 Million | $170.67 Million | $92.83 Million | ▲ +90.9 pp |
| 2023 | 100.9% | $197.86 Million | $196.01 Million | $285.97 Million | $88.11 Million | ▲ +313.5 pp |
| 2022 | -212.6% | $-15.28 Million | $7.19 Million | $36.18 Million | $51.46 Million | ▼ -378.2 pp |
| 2021 | 165.6% | $42.95 Million | $25.93 Million | $75.21 Million | $32.26 Million | ▲ +63.6 pp |
| 2020 | 102.0% | $18.26 Million | $17.90 Million | $37.67 Million | $19.41 Million | ▲ +70.5 pp |
| 2019 | 31.5% | $5.85 Million | $18.59 Million | $18.24 Million | $12.39 Million | ▼ -4.6 pp |
| 2018 | 36.0% | $12.48 Million | $34.66 Million | $20.98 Million | $8.49 Million | ▲ +4.0 pp |
| 2017 | 32.0% | $15.44 Million | $48.18 Million | $20.88 Million | $5.44 Million | ▼ -10.8 pp |
| 2016 | 42.8% | $24.29 Million | $56.72 Million | $27.84 Million | $3.55 Million | ▼ -12.1 pp |
| 2015 | 54.9% | $39.43 Million | $71.77 Million | $43.15 Million | $3.72 Million | ▲ +43.9 pp |
| 2014 | 11.0% | $3.75 Million | $33.94 Million | $5.64 Million | $1.89 Million | ▲ +0.8 pp |
| 2013 | 10.2% | $3.48 Million | $34.02 Million | $5.60 Million | $2.12 Million | — |